Dialysis fluid removal trial aims to ease heart strain

NCT ID NCT07637110

Not yet recruiting Disease control Sponsor: University of Washington Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding extra ultrafiltration (a gentle fluid-removal procedure) for 4 or 8 weeks can safely reduce excess fluid in people on hemodialysis. The goal is to lower high blood pressure and relieve symptoms like congestion. About 120 adults with end-stage kidney disease and signs of fluid overload will take part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ultrafiltration (a gentle fluid-removal procedure during dialysis)
What this could lead to: If successful, this could offer a simple way to reduce high blood pressure and fluid-related symptoms in dialysis patients, potentially lowering hospitalizations.
What could go wrong: This is a small, early-stage trial with only 120 participants. The extra fluid removal may cause side effects like low blood pressure or cramps, and benefits may not last long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOOD PRESSURE MANAGEMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease Edema end stage renal failure hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLOOD PRESSURE MANAGEMENT END STAGE RENAL DISEASE (ESRD) FLUID ACCUMULATION

Contacts and locations

Locations

Northwest Kidney Centers

Seattle, Washington, 98112, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.